Tevogen Bio Holdings Inc.
TVGN
$7.00
-$2.54-26.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 39.61% | -91.41% | -292.20% | -425.62% | -91.58% |
| Total Depreciation and Amortization | 12.74% | 26.20% | 31.43% | 53.11% | 6.51% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Other Non-Cash Items | -48.49% | 2,946.02% | 524.68% | 421.80% | 171.34% |
| Change in Net Operating Assets | -191.49% | -49,436.36% | -609.54% | -253.41% | -215.61% |
| Cash from Operations | 10.57% | -2.75% | -20.75% | -49.62% | -61.11% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 13.33% | 240.00% | 151.85% | 193.33% | 100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 261.81% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -77.78% | 20.00% | 300.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -143.61% | -133.16% | -100.00% | -100.00% |
| Cash from Financing | -23.65% | -4.64% | 11.73% | 95.41% | 263.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -295.22% | -416.83% | -368.87% | 80.60% | 115.08% |